MedTrace Logo

Morphine In Acute Myocardial Infarction

NCT01186445 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 94

Last updated 2017-02-06

No results posted yet for this study

Summary

The purpose of this study is to determine whether intracoronary injection of morphine chlorhydrate is effective to limit ischemia-reperfusion lesion during percutaneous coronary angioplasty in patients with acute myocardial infarction (AMI).

Conditions

  • Acute Myocardial Infarction

Interventions

DRUG

morphine chlorhydrate

1mg of morphine chlorhydrate dilute in 3ml of saline solution, intracoronary injection, just before reperfusion

DRUG

saline solution

3 ml of saline solution , intracoronary injection during reperfusion

Sponsors & Collaborators

  • Institut National de la Santé Et de la Recherche Médicale, France

    collaborator OTHER_GOV

  • French Cardiology Society

    lead OTHER

Principal Investigators

  • Philippe Lecorvoisier, MD · Henri Mondor University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01186445 on ClinicalTrials.gov